CorMedix (CRMD) Return on Sales (2013 - 2025)

CorMedix has disclosed Return on Sales across 12 years of filings, most recently posting 0.0% for Q4 2025.

• Return on Sales for Q4 2025 came in at 0.0%, down 1.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.01% (changed 0.0% YoY), and the FY2025 annual result was 0.01%, changed 0.0% from the prior year.
• Return on Sales came in at 0.0% for Q4 2025 at CorMedix, down from 0.01% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.01% in Q4 2024 to a low of 10.05% in Q3 2022.
• The 4-year median for Return on Sales is 0.82% (2021), against an average of 2.41%.
• Peak annual rise in Return on Sales reached 208 bps in 2022, while the deepest fall reached 838 bps in 2022.
• CorMedix's Return on Sales stood at 1.71% in 2021, then sank by 61 bps to 2.76% in 2022, then surged by 100 bps to 0.01% in 2024, then sank by 90 bps to 0.0% in 2025.
• The last three Return on Sales figures came in at 0.0% (Q4 2025), 0.01% (Q3 2025), and 0.0% (Q2 2025), per Business Quant data.